Novo obesity partner nabs Pfizer vet as CBO; CureVac’s leadership clears out as BioNTech takes overnews2025-12-19T12:00:17+00:00December 19th, 2025|Endpoints News|
Centessa CEO to step down; John Maraganore, Clive Meanwell find CMO for their new cardio betnews2025-12-12T12:00:38+00:00December 12th, 2025|Endpoints News|
Ex-Intercept CEO to take over at Altimmune; Carolyn Bertozzi leaves Alnylam’s boardnews2025-12-05T12:00:12+00:00December 5th, 2025|Endpoints News|
Jeff Bluestone, Stephen Dilly talk CEO handoff, what’s next for Sonoma; Scott Gottlieb’s next movenews2025-11-21T12:00:57+00:00November 21st, 2025|Endpoints News|
Mikael Dolsten removes himself from board candidacy at Novo; Bavarian Nordic chairman resignsnews2025-11-14T12:00:22+00:00November 14th, 2025|Endpoints News|
Novo Nordisk, Pfizer make personnel waves as they squabble over Metseranews2025-11-07T12:00:59+00:00November 7th, 2025|Endpoints News|
OrbiMed-backed biotech quickly changes CEOs; Adaptimmune co-founder to lead Evaxionnews2025-10-31T11:00:30+00:00October 31st, 2025|Endpoints News|
Novo Nordisk lines up corporate affairs exec, overshadowed by board dramanews2025-10-24T11:00:57+00:00October 24th, 2025|Endpoints News|
Boehringer Ingelheim names global obesity leader; Calico taps AbbVie vet for discovery rolenews2025-10-17T11:00:38+00:00October 17th, 2025|Endpoints News|
Shape’s former CSO picks up tech role at Moderna; Lilly reels in Peter Marksnews2025-10-10T11:00:39+00:00October 10th, 2025|Endpoints News|
